nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—CXCL8—atherosclerosis	0.339	0.483	CbGaD
Tolmetin—MPO—atherosclerosis	0.264	0.376	CbGaD
Tolmetin—PTGS2—atherosclerosis	0.099	0.141	CbGaD
Tolmetin—MPO—superior mesenteric artery—atherosclerosis	0.0289	0.463	CbGeAlD
Tolmetin—SLC22A6—Pravastatin—atherosclerosis	0.0244	1	CbGbCtD
Tolmetin—MPO—artery—atherosclerosis	0.00309	0.0495	CbGeAlD
Tolmetin—MPO—endothelium—atherosclerosis	0.00261	0.0418	CbGeAlD
Tolmetin—PTGS2—leg—atherosclerosis	0.00256	0.041	CbGeAlD
Tolmetin—MPO—blood vessel—atherosclerosis	0.00241	0.0385	CbGeAlD
Tolmetin—PTGS2—hindlimb—atherosclerosis	0.00228	0.0366	CbGeAlD
Tolmetin—Proteinuria—Rosuvastatin—atherosclerosis	0.00217	0.0255	CcSEcCtD
Tolmetin—Protein urine present—Rosuvastatin—atherosclerosis	0.00214	0.0252	CcSEcCtD
Tolmetin—TDO2—liver—atherosclerosis	0.00206	0.033	CbGeAlD
Tolmetin—PTGS2—appendage—atherosclerosis	0.00196	0.0314	CbGeAlD
Tolmetin—Proteinuria—Simvastatin—atherosclerosis	0.00172	0.0202	CcSEcCtD
Tolmetin—Protein urine present—Simvastatin—atherosclerosis	0.0017	0.0199	CcSEcCtD
Tolmetin—CXCL8—adipose tissue—atherosclerosis	0.00162	0.0259	CbGeAlD
Tolmetin—Indomethacin—PLA2G2A—atherosclerosis	0.00161	0.333	CrCbGaD
Tolmetin—PTGS1—artery—atherosclerosis	0.00146	0.0235	CbGeAlD
Tolmetin—PTGS2—artery—atherosclerosis	0.0014	0.0224	CbGeAlD
Tolmetin—Vascular purpura—Lovastatin—atherosclerosis	0.00131	0.0154	CcSEcCtD
Tolmetin—Haemolytic anaemia—Lovastatin—atherosclerosis	0.0013	0.0153	CcSEcCtD
Tolmetin—PTGS1—endothelium—atherosclerosis	0.00124	0.0198	CbGeAlD
Tolmetin—MPO—connective tissue—atherosclerosis	0.00123	0.0198	CbGeAlD
Tolmetin—Vascular purpura—Simvastatin—atherosclerosis	0.00123	0.0144	CcSEcCtD
Tolmetin—Purpura—Lovastatin—atherosclerosis	0.00122	0.0143	CcSEcCtD
Tolmetin—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00122	0.0143	CcSEcCtD
Tolmetin—PTGS2—endothelium—atherosclerosis	0.00118	0.019	CbGeAlD
Tolmetin—PTGS1—blood vessel—atherosclerosis	0.00114	0.0183	CbGeAlD
Tolmetin—Purpura—Simvastatin—atherosclerosis	0.00114	0.0134	CcSEcCtD
Tolmetin—CXCL8—liver—atherosclerosis	0.00113	0.0182	CbGeAlD
Tolmetin—Vascular purpura—Pravastatin—atherosclerosis	0.00111	0.013	CcSEcCtD
Tolmetin—Haemolytic anaemia—Pravastatin—atherosclerosis	0.0011	0.0129	CcSEcCtD
Tolmetin—PTGS2—blood vessel—atherosclerosis	0.00109	0.0175	CbGeAlD
Tolmetin—MPO—cardiovascular system—atherosclerosis	0.00107	0.0172	CbGeAlD
Tolmetin—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00106	0.0124	CcSEcCtD
Tolmetin—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00104	0.0122	CcSEcCtD
Tolmetin—Purpura—Pravastatin—atherosclerosis	0.00103	0.0121	CcSEcCtD
Tolmetin—Gastritis—Ezetimibe—atherosclerosis	0.00102	0.012	CcSEcCtD
Tolmetin—Haematuria—Rosuvastatin—atherosclerosis	0.00102	0.012	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00101	0.0118	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000988	0.0116	CcSEcCtD
Tolmetin—Abdominal discomfort—Lovastatin—atherosclerosis	0.000972	0.0114	CcSEcCtD
Tolmetin—Gastritis—Simvastatin—atherosclerosis	0.000971	0.0114	CcSEcCtD
Tolmetin—Hepatitis—Rosuvastatin—atherosclerosis	0.000958	0.0113	CcSEcCtD
Tolmetin—Abdominal discomfort—Simvastatin—atherosclerosis	0.000909	0.0107	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000893	0.0105	CcSEcCtD
Tolmetin—Urinary tract infection—Lovastatin—atherosclerosis	0.000879	0.0103	CcSEcCtD
Tolmetin—Flatulence—Rosuvastatin—atherosclerosis	0.000822	0.00965	CcSEcCtD
Tolmetin—Hepatitis—Lovastatin—atherosclerosis	0.000812	0.00954	CcSEcCtD
Tolmetin—Dysuria—Pravastatin—atherosclerosis	0.000802	0.00942	CcSEcCtD
Tolmetin—Hepatitis—Ezetimibe—atherosclerosis	0.000796	0.00935	CcSEcCtD
Tolmetin—Weight increased—Pravastatin—atherosclerosis	0.00078	0.00917	CcSEcCtD
Tolmetin—Weight decreased—Pravastatin—atherosclerosis	0.000776	0.00912	CcSEcCtD
Tolmetin—Erythema multiforme—Lovastatin—atherosclerosis	0.000767	0.00902	CcSEcCtD
Tolmetin—Hepatitis—Simvastatin—atherosclerosis	0.000759	0.00892	CcSEcCtD
Tolmetin—Stomatitis—Niacin—atherosclerosis	0.000757	0.00889	CcSEcCtD
Tolmetin—Erythema multiforme—Ezetimibe—atherosclerosis	0.000753	0.00884	CcSEcCtD
Tolmetin—Urinary tract infection—Pravastatin—atherosclerosis	0.000743	0.00873	CcSEcCtD
Tolmetin—Erythema multiforme—Simvastatin—atherosclerosis	0.000718	0.00843	CcSEcCtD
Tolmetin—Hepatitis—Niacin—atherosclerosis	0.000697	0.00819	CcSEcCtD
Tolmetin—Flatulence—Lovastatin—atherosclerosis	0.000696	0.00818	CcSEcCtD
Tolmetin—Indomethacin—PPARA—atherosclerosis	0.000691	0.143	CrCbGaD
Tolmetin—Hepatitis—Pravastatin—atherosclerosis	0.000686	0.00806	CcSEcCtD
Tolmetin—Flatulence—Ezetimibe—atherosclerosis	0.000683	0.00802	CcSEcCtD
Tolmetin—Visual impairment—Niacin—atherosclerosis	0.000672	0.00789	CcSEcCtD
Tolmetin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000666	0.00783	CcSEcCtD
Tolmetin—MPO—liver—atherosclerosis	0.000664	0.0106	CbGeAlD
Tolmetin—Visual impairment—Pravastatin—atherosclerosis	0.000661	0.00777	CcSEcCtD
Tolmetin—Flatulence—Simvastatin—atherosclerosis	0.000651	0.00765	CcSEcCtD
Tolmetin—Tinnitus—Niacin—atherosclerosis	0.00065	0.00764	CcSEcCtD
Tolmetin—Erythema multiforme—Pravastatin—atherosclerosis	0.000649	0.00763	CcSEcCtD
Tolmetin—Tinnitus—Pravastatin—atherosclerosis	0.00064	0.00752	CcSEcCtD
Tolmetin—Chest pain—Lovastatin—atherosclerosis	0.000602	0.00707	CcSEcCtD
Tolmetin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000599	0.00704	CcSEcCtD
Tolmetin—Flatulence—Niacin—atherosclerosis	0.000598	0.00703	CcSEcCtD
Tolmetin—Chest pain—Ezetimibe—atherosclerosis	0.00059	0.00693	CcSEcCtD
Tolmetin—Flatulence—Pravastatin—atherosclerosis	0.000589	0.00692	CcSEcCtD
Tolmetin—PTGS1—connective tissue—atherosclerosis	0.000585	0.00938	CbGeAlD
Tolmetin—Constipation—Rosuvastatin—atherosclerosis	0.000582	0.00684	CcSEcCtD
Tolmetin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000577	0.00678	CcSEcCtD
Tolmetin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000566	0.00665	CcSEcCtD
Tolmetin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000565	0.00663	CcSEcCtD
Tolmetin—Chest pain—Simvastatin—atherosclerosis	0.000563	0.00661	CcSEcCtD
Tolmetin—PTGS2—connective tissue—atherosclerosis	0.000559	0.00896	CbGeAlD
Tolmetin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000556	0.00654	CcSEcCtD
Tolmetin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000554	0.00651	CcSEcCtD
Tolmetin—Urticaria—Rosuvastatin—atherosclerosis	0.000541	0.00635	CcSEcCtD
Tolmetin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000539	0.00634	CcSEcCtD
Tolmetin—Oedema—Simvastatin—atherosclerosis	0.000539	0.00634	CcSEcCtD
Tolmetin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000538	0.00632	CcSEcCtD
Tolmetin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000528	0.00621	CcSEcCtD
Tolmetin—PTGS1—cardiovascular system—atherosclerosis	0.000509	0.00816	CbGeAlD
Tolmetin—Chest pain—Pravastatin—atherosclerosis	0.000509	0.00598	CcSEcCtD
Tolmetin—Dyspepsia—Lovastatin—atherosclerosis	0.000508	0.00596	CcSEcCtD
Tolmetin—Dyspepsia—Ezetimibe—atherosclerosis	0.000498	0.00585	CcSEcCtD
Tolmetin—Anaphylactic shock—Niacin—atherosclerosis	0.000495	0.00582	CcSEcCtD
Tolmetin—Oedema—Niacin—atherosclerosis	0.000495	0.00582	CcSEcCtD
Tolmetin—Constipation—Lovastatin—atherosclerosis	0.000493	0.00579	CcSEcCtD
Tolmetin—Asthenia—Rosuvastatin—atherosclerosis	0.000488	0.00574	CcSEcCtD
Tolmetin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000488	0.00573	CcSEcCtD
Tolmetin—Oedema—Pravastatin—atherosclerosis	0.000488	0.00573	CcSEcCtD
Tolmetin—PTGS2—cardiovascular system—atherosclerosis	0.000487	0.0078	CbGeAlD
Tolmetin—Constipation—Ezetimibe—atherosclerosis	0.000484	0.00568	CcSEcCtD
Tolmetin—Indomethacin—CXCL8—atherosclerosis	0.000479	0.0988	CrCbGaD
Tolmetin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000477	0.00561	CcSEcCtD
Tolmetin—Dyspepsia—Simvastatin—atherosclerosis	0.000475	0.00558	CcSEcCtD
Tolmetin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000472	0.00554	CcSEcCtD
Tolmetin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000466	0.00547	CcSEcCtD
Tolmetin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000463	0.00543	CcSEcCtD
Tolmetin—Constipation—Simvastatin—atherosclerosis	0.000461	0.00542	CcSEcCtD
Tolmetin—Urticaria—Lovastatin—atherosclerosis	0.000458	0.00538	CcSEcCtD
Tolmetin—Abdominal pain—Lovastatin—atherosclerosis	0.000456	0.00536	CcSEcCtD
Tolmetin—Body temperature increased—Lovastatin—atherosclerosis	0.000456	0.00536	CcSEcCtD
Tolmetin—Dizziness—Rosuvastatin—atherosclerosis	0.00045	0.00529	CcSEcCtD
Tolmetin—Urticaria—Ezetimibe—atherosclerosis	0.000449	0.00528	CcSEcCtD
Tolmetin—PTGS1—adipose tissue—atherosclerosis	0.000449	0.00719	CbGeAlD
Tolmetin—Body temperature increased—Ezetimibe—atherosclerosis	0.000447	0.00525	CcSEcCtD
Tolmetin—Abdominal pain—Ezetimibe—atherosclerosis	0.000447	0.00525	CcSEcCtD
Tolmetin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000441	0.00518	CcSEcCtD
Tolmetin—Somnolence—Niacin—atherosclerosis	0.00044	0.00517	CcSEcCtD
Tolmetin—Dyspepsia—Niacin—atherosclerosis	0.000436	0.00512	CcSEcCtD
Tolmetin—Dyspepsia—Pravastatin—atherosclerosis	0.000429	0.00504	CcSEcCtD
Tolmetin—PTGS2—adipose tissue—atherosclerosis	0.000429	0.00688	CbGeAlD
Tolmetin—Urticaria—Simvastatin—atherosclerosis	0.000429	0.00503	CcSEcCtD
Tolmetin—Body temperature increased—Simvastatin—atherosclerosis	0.000426	0.00501	CcSEcCtD
Tolmetin—Abdominal pain—Simvastatin—atherosclerosis	0.000426	0.00501	CcSEcCtD
Tolmetin—Headache—Rosuvastatin—atherosclerosis	0.000426	0.00501	CcSEcCtD
Tolmetin—Constipation—Pravastatin—atherosclerosis	0.000417	0.0049	CcSEcCtD
Tolmetin—Asthenia—Lovastatin—atherosclerosis	0.000414	0.00486	CcSEcCtD
Tolmetin—Asthenia—Ezetimibe—atherosclerosis	0.000406	0.00477	CcSEcCtD
Tolmetin—Gastrointestinal pain—Niacin—atherosclerosis	0.000405	0.00476	CcSEcCtD
Tolmetin—Nausea—Rosuvastatin—atherosclerosis	0.000404	0.00475	CcSEcCtD
Tolmetin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000399	0.00469	CcSEcCtD
Tolmetin—Diarrhoea—Lovastatin—atherosclerosis	0.000395	0.00464	CcSEcCtD
Tolmetin—Urticaria—Niacin—atherosclerosis	0.000393	0.00462	CcSEcCtD
Tolmetin—Body temperature increased—Niacin—atherosclerosis	0.000392	0.0046	CcSEcCtD
Tolmetin—Abdominal pain—Niacin—atherosclerosis	0.000392	0.0046	CcSEcCtD
Tolmetin—Urticaria—Pravastatin—atherosclerosis	0.000387	0.00455	CcSEcCtD
Tolmetin—Asthenia—Simvastatin—atherosclerosis	0.000387	0.00455	CcSEcCtD
Tolmetin—Diarrhoea—Ezetimibe—atherosclerosis	0.000387	0.00455	CcSEcCtD
Tolmetin—Body temperature increased—Pravastatin—atherosclerosis	0.000386	0.00453	CcSEcCtD
Tolmetin—Abdominal pain—Pravastatin—atherosclerosis	0.000386	0.00453	CcSEcCtD
Tolmetin—Dizziness—Lovastatin—atherosclerosis	0.000381	0.00448	CcSEcCtD
Tolmetin—Dizziness—Ezetimibe—atherosclerosis	0.000374	0.00439	CcSEcCtD
Tolmetin—Diarrhoea—Simvastatin—atherosclerosis	0.000369	0.00434	CcSEcCtD
Tolmetin—Vomiting—Lovastatin—atherosclerosis	0.000367	0.00431	CcSEcCtD
Tolmetin—Headache—Lovastatin—atherosclerosis	0.000361	0.00424	CcSEcCtD
Tolmetin—Vomiting—Ezetimibe—atherosclerosis	0.00036	0.00423	CcSEcCtD
Tolmetin—Dizziness—Simvastatin—atherosclerosis	0.000357	0.00419	CcSEcCtD
Tolmetin—Ketorolac—PTGS2—atherosclerosis	0.000356	0.0733	CrCbGaD
Tolmetin—Asthenia—Niacin—atherosclerosis	0.000355	0.00418	CcSEcCtD
Tolmetin—Headache—Ezetimibe—atherosclerosis	0.000354	0.00416	CcSEcCtD
Tolmetin—Asthenia—Pravastatin—atherosclerosis	0.00035	0.00411	CcSEcCtD
Tolmetin—Vomiting—Simvastatin—atherosclerosis	0.000343	0.00403	CcSEcCtD
Tolmetin—Nausea—Lovastatin—atherosclerosis	0.000343	0.00402	CcSEcCtD
Tolmetin—Bromfenac—PTGS2—atherosclerosis	0.000341	0.0703	CrCbGaD
Tolmetin—Diarrhoea—Niacin—atherosclerosis	0.000339	0.00398	CcSEcCtD
Tolmetin—Headache—Simvastatin—atherosclerosis	0.000338	0.00397	CcSEcCtD
Tolmetin—Nausea—Ezetimibe—atherosclerosis	0.000336	0.00395	CcSEcCtD
Tolmetin—Diarrhoea—Pravastatin—atherosclerosis	0.000334	0.00392	CcSEcCtD
Tolmetin—Indomethacin—PPARG—atherosclerosis	0.000331	0.0683	CrCbGaD
Tolmetin—Dizziness—Niacin—atherosclerosis	0.000328	0.00385	CcSEcCtD
Tolmetin—Dizziness—Pravastatin—atherosclerosis	0.000322	0.00379	CcSEcCtD
Tolmetin—Nausea—Simvastatin—atherosclerosis	0.00032	0.00376	CcSEcCtD
Tolmetin—Vomiting—Niacin—atherosclerosis	0.000315	0.0037	CcSEcCtD
Tolmetin—Headache—Niacin—atherosclerosis	0.00031	0.00365	CcSEcCtD
Tolmetin—Vomiting—Pravastatin—atherosclerosis	0.00031	0.00364	CcSEcCtD
Tolmetin—Headache—Pravastatin—atherosclerosis	0.000305	0.00359	CcSEcCtD
Tolmetin—PTGS2—liver—atherosclerosis	0.000301	0.00482	CbGeAlD
Tolmetin—Nausea—Niacin—atherosclerosis	0.000294	0.00346	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—atherosclerosis	0.00029	0.0598	CrCbGaD
Tolmetin—Nausea—Pravastatin—atherosclerosis	0.00029	0.0034	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—atherosclerosis	0.000264	0.0544	CrCbGaD
Tolmetin—Suprofen—PTGS2—atherosclerosis	0.00022	0.0453	CrCbGaD
Tolmetin—Indomethacin—PTGS2—atherosclerosis	0.00014	0.0288	CrCbGaD
Tolmetin—Indomethacin—ALB—atherosclerosis	0.000124	0.0257	CrCbGaD
Tolmetin—CXCL8—Signaling by GPCR—AGTR1—atherosclerosis	3.38e-05	0.00028	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—atherosclerosis	3.37e-05	0.00028	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	3.33e-05	0.000276	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ALB—atherosclerosis	3.31e-05	0.000274	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP1—atherosclerosis	3.3e-05	0.000273	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—AGT—atherosclerosis	3.26e-05	0.00027	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CX3CR1—atherosclerosis	3.24e-05	0.000269	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASR—atherosclerosis	3.24e-05	0.000269	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	3.2e-05	0.000265	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—LEP—atherosclerosis	3.19e-05	0.000264	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CX3CL1—atherosclerosis	3.18e-05	0.000264	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NOS3—atherosclerosis	3.16e-05	0.000262	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.16e-05	0.000262	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—EDN1—atherosclerosis	3.15e-05	0.000261	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.14e-05	0.000261	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCL5—atherosclerosis	3.13e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.12e-05	0.000259	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.12e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.1e-05	0.000257	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.05e-05	0.000253	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CNR2—atherosclerosis	3.02e-05	0.00025	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MMP3—atherosclerosis	3.01e-05	0.000249	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—F2—atherosclerosis	3.01e-05	0.000249	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	2.99e-05	0.000248	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PRKCG—atherosclerosis	2.97e-05	0.000246	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LTA4H—atherosclerosis	2.96e-05	0.000245	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCG8—atherosclerosis	2.96e-05	0.000245	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCG1—atherosclerosis	2.95e-05	0.000244	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.92e-05	0.000242	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	2.91e-05	0.000241	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—atherosclerosis	2.89e-05	0.00024	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EDN1—atherosclerosis	2.86e-05	0.000237	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL5—atherosclerosis	2.84e-05	0.000235	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	2.82e-05	0.000234	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—FABP4—atherosclerosis	2.77e-05	0.00023	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LCAT—atherosclerosis	2.77e-05	0.00023	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.76e-05	0.000229	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—INS—atherosclerosis	2.73e-05	0.000226	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOA4—atherosclerosis	2.72e-05	0.000225	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PRKCG—atherosclerosis	2.7e-05	0.000224	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VWF—atherosclerosis	2.69e-05	0.000223	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	2.69e-05	0.000223	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CCL2—atherosclerosis	2.68e-05	0.000222	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOC3—atherosclerosis	2.67e-05	0.000221	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP7A1—atherosclerosis	2.67e-05	0.000221	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LDLR—atherosclerosis	2.66e-05	0.00022	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—IGF1—atherosclerosis	2.64e-05	0.000219	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	2.63e-05	0.000218	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AGT—atherosclerosis	2.62e-05	0.000217	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL3—atherosclerosis	2.59e-05	0.000215	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOA4—atherosclerosis	2.58e-05	0.000214	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP2—atherosclerosis	2.55e-05	0.000212	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—atherosclerosis	2.55e-05	0.000211	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.55e-05	0.000211	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.52e-05	0.000209	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NCF1—atherosclerosis	2.48e-05	0.000206	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP27A1—atherosclerosis	2.47e-05	0.000205	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.46e-05	0.000204	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.43e-05	0.000202	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—F2—atherosclerosis	2.42e-05	0.0002	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AGT—atherosclerosis	2.38e-05	0.000197	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.37e-05	0.000197	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.37e-05	0.000196	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EDNRA—atherosclerosis	2.35e-05	0.000194	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR2—atherosclerosis	2.35e-05	0.000194	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOA2—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALOX5AP—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALOX15—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PLA2G2A—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCG1—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CYBA—atherosclerosis	2.33e-05	0.000194	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CG—atherosclerosis	2.31e-05	0.000192	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCG5—atherosclerosis	2.31e-05	0.000192	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.31e-05	0.000191	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.3e-05	0.000191	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GHRL—atherosclerosis	2.29e-05	0.000189	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PLAT—atherosclerosis	2.29e-05	0.000189	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PARP1—atherosclerosis	2.29e-05	0.000189	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.26e-05	0.000188	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LPA—atherosclerosis	2.23e-05	0.000185	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOA2—atherosclerosis	2.22e-05	0.000184	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—FABP4—atherosclerosis	2.2e-05	0.000182	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LCAT—atherosclerosis	2.2e-05	0.000182	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—F2—atherosclerosis	2.19e-05	0.000182	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—BGN—atherosclerosis	2.16e-05	0.000179	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOA4—atherosclerosis	2.16e-05	0.000179	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.15e-05	0.000178	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOA5—atherosclerosis	2.14e-05	0.000177	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	2.13e-05	0.000176	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP7A1—atherosclerosis	2.12e-05	0.000176	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CG—atherosclerosis	2.1e-05	0.000174	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.09e-05	0.000173	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.08e-05	0.000172	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PLA2G1B—atherosclerosis	2.06e-05	0.000171	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BGN—atherosclerosis	2.05e-05	0.00017	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.04e-05	0.000169	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.02e-05	0.000168	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.02e-05	0.000167	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.01e-05	0.000167	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KNG1—atherosclerosis	2.01e-05	0.000166	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AGTR1—atherosclerosis	1.99e-05	0.000165	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALOX5—atherosclerosis	1.99e-05	0.000165	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.98e-05	0.000164	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP27A1—atherosclerosis	1.96e-05	0.000162	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL2—atherosclerosis	1.96e-05	0.000162	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PLG—atherosclerosis	1.94e-05	0.000161	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.93e-05	0.00016	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.92e-05	0.000159	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.88e-05	0.000156	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	1.87e-05	0.000155	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PLA2G2A—atherosclerosis	1.86e-05	0.000154	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOA2—atherosclerosis	1.86e-05	0.000154	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALOX5AP—atherosclerosis	1.86e-05	0.000154	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALOX15—atherosclerosis	1.86e-05	0.000154	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SOCS3—atherosclerosis	1.84e-05	0.000153	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.84e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCG5—atherosclerosis	1.84e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.83e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.79e-05	0.000149	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CST3—atherosclerosis	1.79e-05	0.000148	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NAMPT—atherosclerosis	1.79e-05	0.000148	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP3—atherosclerosis	1.78e-05	0.000147	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.77e-05	0.000147	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LIPC—atherosclerosis	1.77e-05	0.000147	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LPA—atherosclerosis	1.77e-05	0.000147	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF2—atherosclerosis	1.77e-05	0.000147	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOC3—atherosclerosis	1.76e-05	0.000146	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LDLR—atherosclerosis	1.75e-05	0.000145	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOB—atherosclerosis	1.72e-05	0.000142	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—BGN—atherosclerosis	1.72e-05	0.000142	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CETP—atherosclerosis	1.71e-05	0.000142	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.7e-05	0.000141	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOA5—atherosclerosis	1.7e-05	0.000141	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NAMPT—atherosclerosis	1.69e-05	0.00014	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EDN1—atherosclerosis	1.69e-05	0.00014	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL5—atherosclerosis	1.68e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOC3—atherosclerosis	1.67e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LDLR—atherosclerosis	1.66e-05	0.000138	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.65e-05	0.000137	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LPL—atherosclerosis	1.64e-05	0.000136	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SCARB1—atherosclerosis	1.64e-05	0.000136	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PLA2G1B—atherosclerosis	1.64e-05	0.000136	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.62e-05	0.000134	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HSPA1B—atherosclerosis	1.6e-05	0.000133	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.6e-05	0.000133	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.6e-05	0.000133	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.6e-05	0.000132	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRKCG—atherosclerosis	1.59e-05	0.000132	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALOX5—atherosclerosis	1.58e-05	0.000131	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SPP1—atherosclerosis	1.55e-05	0.000129	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NCF1—atherosclerosis	1.55e-05	0.000129	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HMGCR—atherosclerosis	1.55e-05	0.000128	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CYBA—atherosclerosis	1.46e-05	0.000121	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.46e-05	0.000121	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—atherosclerosis	1.45e-05	0.000121	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDGFB—atherosclerosis	1.44e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PARP1—atherosclerosis	1.43e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NAMPT—atherosclerosis	1.42e-05	0.000117	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.41e-05	0.000117	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LIPC—atherosclerosis	1.41e-05	0.000117	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AGT—atherosclerosis	1.4e-05	0.000116	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOC3—atherosclerosis	1.4e-05	0.000116	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.4e-05	0.000116	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LDLR—atherosclerosis	1.39e-05	0.000115	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCA1—atherosclerosis	1.38e-05	0.000114	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOE—atherosclerosis	1.37e-05	0.000114	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LEP—atherosclerosis	1.37e-05	0.000114	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CAV1—atherosclerosis	1.36e-05	0.000113	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOA1—atherosclerosis	1.36e-05	0.000113	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CETP—atherosclerosis	1.36e-05	0.000113	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.33e-05	0.000111	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ESR1—atherosclerosis	1.31e-05	0.000109	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SCARB1—atherosclerosis	1.3e-05	0.000108	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—F2—atherosclerosis	1.3e-05	0.000107	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.27e-05	0.000105	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CG—atherosclerosis	1.24e-05	0.000103	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HMGCR—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK3—atherosclerosis	1.19e-05	9.85e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HMOX1—atherosclerosis	1.18e-05	9.81e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—INS—atherosclerosis	1.17e-05	9.74e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL2—atherosclerosis	1.16e-05	9.58e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF1—atherosclerosis	1.14e-05	9.42e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOB—atherosclerosis	1.13e-05	9.4e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—atherosclerosis	1.1e-05	9.14e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCA1—atherosclerosis	1.1e-05	9.08e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LPL—atherosclerosis	1.08e-05	8.97e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SERPINE1—atherosclerosis	1.08e-05	8.94e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOB—atherosclerosis	1.07e-05	8.91e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPX1—atherosclerosis	1.06e-05	8.76e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOS3—atherosclerosis	1.03e-05	8.54e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CD36—atherosclerosis	1.03e-05	8.53e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LPL—atherosclerosis	1.03e-05	8.51e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PRKCG—atherosclerosis	9.98e-06	8.27e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTHFR—atherosclerosis	9.75e-06	8.08e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARA—atherosclerosis	9.56e-06	7.93e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HMOX1—atherosclerosis	9.4e-06	7.79e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AGT—atherosclerosis	9.26e-06	7.68e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTHFR—atherosclerosis	9.24e-06	7.66e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOE—atherosclerosis	9.07e-06	7.52e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOB—atherosclerosis	9e-06	7.46e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PDGFB—atherosclerosis	8.99e-06	7.46e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CAV1—atherosclerosis	8.99e-06	7.45e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOA1—atherosclerosis	8.97e-06	7.44e-05	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—atherosclerosis	8.83e-06	7.32e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—atherosclerosis	8.75e-06	7.26e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—atherosclerosis	8.69e-06	7.2e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOE—atherosclerosis	8.6e-06	7.13e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LPL—atherosclerosis	8.59e-06	7.12e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CAV1—atherosclerosis	8.52e-06	7.06e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOA1—atherosclerosis	8.5e-06	7.05e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPX1—atherosclerosis	8.38e-06	6.95e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—atherosclerosis	8.26e-06	6.85e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CG—atherosclerosis	8.19e-06	6.79e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NFKB1—atherosclerosis	8.18e-06	6.78e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CD36—atherosclerosis	8.16e-06	6.77e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK8—atherosclerosis	8.04e-06	6.66e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—atherosclerosis	8.02e-06	6.65e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS2—atherosclerosis	8.01e-06	6.64e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARG—atherosclerosis	7.9e-06	6.55e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—INS—atherosclerosis	7.75e-06	6.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTHFR—atherosclerosis	7.74e-06	6.41e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARA—atherosclerosis	7.59e-06	6.29e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—atherosclerosis	7.42e-06	6.15e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AGT—atherosclerosis	7.35e-06	6.09e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—atherosclerosis	7.35e-06	6.09e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—INS—atherosclerosis	7.35e-06	6.09e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOE—atherosclerosis	7.2e-06	5.97e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CAV1—atherosclerosis	7.14e-06	5.92e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOA1—atherosclerosis	7.12e-06	5.9e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—atherosclerosis	7.11e-06	5.89e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK3—atherosclerosis	7.02e-06	5.82e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—atherosclerosis	6.81e-06	5.65e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NOS3—atherosclerosis	6.8e-06	5.64e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SERPINE1—atherosclerosis	6.75e-06	5.6e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CG—atherosclerosis	6.5e-06	5.39e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS3—atherosclerosis	6.44e-06	5.34e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARG—atherosclerosis	6.27e-06	5.2e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—atherosclerosis	6.22e-06	5.15e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—INS—atherosclerosis	6.15e-06	5.1e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—atherosclerosis	5.64e-06	4.68e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NOS3—atherosclerosis	5.4e-06	4.47e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—atherosclerosis	5.13e-06	4.26e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—atherosclerosis	4.74e-06	3.93e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—atherosclerosis	4.6e-06	3.81e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK3—atherosclerosis	4.39e-06	3.64e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—atherosclerosis	4.26e-06	3.53e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—atherosclerosis	3.21e-06	2.66e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—atherosclerosis	3.12e-06	2.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—atherosclerosis	2.96e-06	2.46e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—atherosclerosis	2.48e-06	2.06e-05	CbGpPWpGaD
